PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.44%
Revenue growth at 50-75% of 2127.T's 10.84%. Martin Whitman would worry about competitiveness or product relevance.
10.34%
Gross profit growth under 50% of 2127.T's 27.81%. Michael Burry would be concerned about a severe competitive disadvantage.
32.32%
EBIT growth 50-75% of 2127.T's 45.86%. Martin Whitman would suspect suboptimal resource allocation.
35.65%
Operating income growth at 50-75% of 2127.T's 47.81%. Martin Whitman would doubt the firm’s ability to compete efficiently.
36.95%
Net income growth at 50-75% of 2127.T's 49.79%. Martin Whitman would question fundamental disadvantages in expenses or demand.
-31.52%
Negative EPS growth while 2127.T is at 49.22%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-31.52%
Negative diluted EPS growth while 2127.T is at 49.22%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
100.00%
Slight or no buybacks while 2127.T is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
100.00%
Slight or no buyback while 2127.T is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.06%
Negative 10Y revenue/share CAGR while 2127.T stands at 97.34%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-9.06%
Negative 5Y CAGR while 2127.T stands at 97.34%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-21.15%
Negative 3Y CAGR while 2127.T stands at 182.22%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
15.25%
Below 50% of 2127.T's 99.27%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
15.25%
Below 50% of 2127.T's 99.27%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
6.59%
Below 50% of 2127.T's 362.97%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.61%
Negative 3Y equity/share growth while 2127.T is at 74.25%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-99.47%
Firm’s AR is declining while 2127.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.66%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.83%
Positive asset growth while 2127.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-47.19%
We have a declining book value while 2127.T shows 2.31%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-76.30%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
52.94%
We expand SG&A while 2127.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.